Biophore applies to DCGI for emergency-use approval for COVID treatment drug
The company plans to commence commercial production of the product immediately after the approval is received New Delhi: Biophore ...
The company plans to commence commercial production of the product immediately after the approval is received New Delhi: Biophore ...
Earlier, vaccines that had completed clinical studies outside the country were required to carry out 'bridging trials' on Indian ...
Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients New Delhi: The Drugs Controller ...
New Delhi, May 08: The Drugs Controller General of India (DCGI) has given nod for the emergency use of ...
In a letter to the Serum Institute, DCGI said it is permitted to apply the shelf life of nine ...
The All India Drug Action Network (AIDAN) urged the federal government to withdraw permission to Covaxin New Delhi: Questions ...
Vaccine ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials Drug firm ...
Express News Service NEW DELHI: V G Somani, Drug Controller General of India (DCGI) on Sunday announced that the recommendations ...
The approval is expected to kick off one of the world's biggest vaccination drives in coming days in the ...
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council of ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.